Tower Research Capital (TRC)’s Mesoblast MESO Stock Holding History
Bought
Maintained
Sold
Other funds holding MESO
AAP
PM
FFA
Tower Research Capital (TRC)'s MESO Position: Q2 2026 in Review
Tower Research Capital (TRC) reduced its Mesoblast (MESO) stake by 34% in Q2 2026, selling an estimated $12.1K and leaving 1,607 shares worth $21.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3474.
Tower Research Capital (TRC) first reported a position in MESO in Q4 2015 and has held it in 17 quarters since. The position peaked at $88.2K in Q4 2024. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2026.
- Tower Research Capital (TRC) held 1,607 shares of Mesoblast worth $21.7K as of Q2 2026.
- Tower Research Capital (TRC) sold 812 Mesoblast shares in Q2 2026, an estimated $12.1K.
- Mesoblast made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3474 holding.
- Tower Research Capital (TRC) first reported a position in Mesoblast in Q4 2015 and has held it in 17 quarters since.
- Tower Research Capital (TRC)'s Mesoblast position peaked at $88.2K in Q4 2024.
- 72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.